Ingredion (INGR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Achieved record Q4 and strong full-year 2024 results, with double-digit adjusted EPS growth and robust performance in Texture & Healthful Solutions and Food & Industrial Ingredients segments, despite a 9% decline in net sales due to the South Korea business sale.
2024 reorganization and new segment structure enhanced market focus and operational execution, positioning for targeted growth.
Returned $426M to shareholders in 2024, including $216M in share repurchases and $210M in dividends.
Record gross profit and margin for the full year, with operational excellence and cost-saving initiatives exceeding targets.
Strong cash flow from operations enabled increased organic investment and substantial shareholder returns.
Financial highlights
FY 2024 net sales: $7.43B, down 9% year-over-year, mainly due to the South Korea divestiture and lower corn costs; Q4 net sales: $1.8B, down 6%.
FY 2024 adjusted operating income: $1.016B, up 5% year-over-year; Q4 adjusted operating income: $248M, up 22%.
FY 2024 adjusted diluted EPS: $10.65, up $1.23 per share; Q4 adjusted EPS: $2.63, up $0.66 per share.
FY 2024 gross profit margin: 24.1%, up 270 bps from FY 2023; Q4 gross margin: 25%, up 420 bps.
FY 2024 cash from operations: $1.436B, with $295M in capital expenditures and $426M returned to shareholders.
Outlook and guidance
2025 net sales expected to be up low single digits, with adjusted operating income up mid-single digits.
2025 adjusted EPS guidance: $10.75–$11.55; effective tax rate: 26%–27.5%.
2025 capital expenditures projected at $400–$450M, reflecting one-time infrastructure investments.
2025 cash from operations expected at $800–$950M; share repurchase target of at least $100M.
Segment outlook: Texture & Healthful Solutions net sales and operating income up mid- to high single digits; LATAM net sales flat, operating income up mid-single digits; US/CAN net sales down low single digits, operating income flat to down.
Latest events from Ingredion
- Q1 2026 operating income fell on Argo issues and weak volumes, but Texture & Healthful Solutions grew.INGR
Q1 20268 May 2026 - Record adjusted EPS and segment growth in 2025, with a stable 2026 outlook.INGR
Q4 202520 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and major ESG progress.INGR
Proxy filing8 Apr 2026 - Vote on directors, executive pay, and auditor ratification at the May 2026 virtual meeting.INGR
Proxy filing8 Apr 2026 - Record 2025 results and clean label innovation drive strong growth and margin outlook.INGR
Consumer Analyst Group of New York Conference (CAGNY) 202617 Feb 2026 - Q2 adjusted EPS up 24%, margins rose, and 2024 guidance increased despite lower sales.INGR
Q2 20242 Feb 2026 - Record Q3 profit, margin gains, and raised outlook driven by strong execution and cost savings.INGR
Q3 202416 Jan 2026 - Aiming for $3B sales by 2028 with 5%-6% CAGR, driven by innovation and premium texture solutions.INGR
Investor Update14 Jan 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and highlights ESG gains.INGR
Proxy Filing1 Dec 2025